account_id none on file
legal_name Lexeo Therapeutics, Inc.
ticker LXEO
cik 1907108
domain lexeotx.com
linkedin_company_url https://www.linkedin.com/company/lexeo-therapeutics/
entry_point_account_id none on file
name Lexeo Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 19 executives 3 family 0
why_nownone on file
callsnone on file
filings
In connection with the Company’s lease of office space and laboratory space, the Company provided a security deposit to the landlord in the form of a letter of credit totaling $ 1.2 million.
filing / Aug 12, 2026 / receipt
Such cost containment policies and executive orders could substantially and negatively impact the prices we may charge for any approved products, which could harm our valuation, ability to generate revenue and achieve and sustain profitability.
filing / Aug 12, 2026 / receipt
In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.
filing / Aug 12, 2026 / receipt
Leases -As of June 30, 2026, the Company had entered into commitments under lease agreements to rent laboratory and office space and finance equipment (see Note 7).
filing / Aug 12, 2026 / receipt
, fines, settlements, investigations, criminal or civil sanctions, adverse media coverage or suspension or debarment from government contracts, all of which could damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.
filing / Aug 12, 2026 / receipt
If we are unable to successfully manage the challenges of international expansion and operations, our business and operating results could be harmed.
filing / Aug 12, 2026 / receipt
In connection with the Company’s lease of office space and laboratory space, the Company provided a security deposit to the landlord in the form of a letter of credit totaling $ 1.2 million.
filing / May 11, 2026 / receipt
Such cost containment policies and executive orders could substantially and negatively impact the prices we may charge for any approved products, which could harm our valuation, ability to generate revenue and achieve and sustain profitability.
filing / May 11, 2026 / receipt
In addition to continuing pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs.
filing / May 11, 2026 / receipt
Leases -As of March 31, 2026, the Company had entered into commitments under lease agreements to rent laboratory and office space and finance equipment (see Note 7).
filing / May 11, 2026 / receipt
, fines, settlements, investigations, criminal or civil sanctions, adverse media coverage or suspension or debarment from government contracts, all of which could damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.
filing / May 11, 2026 / receipt
If we are unable to successfully manage the challenges of international expansion and operations, our business and operating results could be harmed.
filing / May 11, 2026 / receipt
executives
| Kyle Rasbach | Chief Financial Officer | - | receipt |
| Louis Tamayo | Chief Financial Officer | receipt | |
| Van Hauwermeiren | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-04 | earnings call | scheduled | ir |
changes
| 2025-08-14 | Chief Financial Officer, appointed | sec_8k |
| 2024-12-19 | Chief Financial Officer, appointed | sec_8k |
| 2024-07-08 | Chief Executive Officer, appointed | sec_8k |
mcp_package_hint
slug lexeo-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$